INGREZZA Trademark

Trademark Overview


On Friday, November 11, 2022, a trademark application was filed for INGREZZA with the United States Patent and Trademark Office. The USPTO has given the INGREZZA trademark a serial number of 97673813. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, December 5, 2023. This trademark is owned by Neurocrine Biosciences, Inc.. The INGREZZA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for schizophrenia, adjunctive treatment of schizophrenia, schizoaffective disorder, bipolar disorder, bipolar mania, DiGeorge syndrome, Lesch-Nyhan syndrome, and movement disorders, namely, Myoclonus, chorea associated with Huntington's Disease, Levodopa-induced dyskinesia, dyskinetic cerebral palsy, dystonia, and tics; Pharmaceutical preparations for the treatment of neurological, central nervous system, and movement diseases and disorders
ingrezza

General Information


Serial Number97673813
Word MarkINGREZZA
Filing DateFriday, November 11, 2022
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, December 5, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 10, 2023

Trademark Statements


Description of MarkThe mark consists of a sequence of right pointing arrows and the word "INGREZZA".
Goods and ServicesPharmaceutical preparations for human use for schizophrenia, adjunctive treatment of schizophrenia, schizoaffective disorder, bipolar disorder, bipolar mania, DiGeorge syndrome, Lesch-Nyhan syndrome, and movement disorders, namely, Myoclonus, chorea associated with Huntington's Disease, Levodopa-induced dyskinesia, dyskinetic cerebral palsy, dystonia, and tics; Pharmaceutical preparations for the treatment of neurological, central nervous system, and movement diseases and disorders
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, December 3, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNeurocrine Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Party NameNeurocrine Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events


Event DateEvent Description
Tuesday, November 15, 2022NEW APPLICATION ENTERED
Saturday, December 3, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 6, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, April 19, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 19, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 19, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 19, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 19, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, August 25, 2023ASSIGNED TO EXAMINER
Tuesday, September 5, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 20, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 10, 2023PUBLISHED FOR OPPOSITION
Tuesday, October 10, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 5, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, April 12, 2024DIVISIONAL REQUEST RECEIVED
Friday, April 12, 2024SOU TEAS EXTENSION RECEIVED
Friday, April 12, 2024TEAS STATEMENT OF USE RECEIVED
Friday, April 12, 2024TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, April 23, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL